| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Sep 20, 2024 | Buy(P) | 26K | $18.36 | $476K | 2.1M |
| Sep 20, 2024 | Buy(P) | 45K | $17.48 | $788K | 2.1M |
| Sep 20, 2024 | Buy(P) | 26K | $22.23 | $573K | 2.4M |
| Sep 20, 2024 | Buy(P) | 140K | $20.42 | $2.8M | 2.3M |
| Sep 20, 2024 | Buy(P) | 66K | $19.61 | $1.3M | 2.2M |
| Sep 20, 2024 | Buy(P) | 48K | $21.47 | $1.0M | 2.3M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000929638-24-003217) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Corbus Pharmaceuticals Holdings, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0000929638-24-003217"
Use Arkolith to summarize insider buying and selling at Corbus Pharmaceuticals Holdings, Inc. over the last 90 days and cite the filings.